Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-001738-33Phase 3Completed
Phase 3, randomised trial of levobupivacaine, sufentanil and clonidine (2 arms), sponsored by CHU de Limoges. Primary endpoint: Satisfaction with analgesia. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-001738-33.